Affinivax Obtains $2,500,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8d59a54a-5f99-404b-b591-d80325b65fa0 - Date
2/5/2016 - Company Name
Affinivax - Mailing Address
Undisclosed Cambridge, MA 02139 USA - Company Description
Affinivax is a biotechnology company developing a novel conjugation technology with the goal of designing vaccines that provide broad protection against challenging diseases afflicting children and adults in both the developing and developed worlds. - Website
http://www.affinivax.com - Transaction Type
Venture Equity - Transaction Amount
$2,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
The company intends to advance its lead MAPS vaccine targeting Streptococcus pneumoniae (pneumococcus) towards clinical testing. - M&A Terms
- Venture Investor
Bill & Melinda Gates Foundation
